JIPOAd
PARP
ESID
  • Users Online: 371
  • Print this page
  • Email this page

    Article Cited by others

EDITORIAL

Cancer immunotherapy for the immunosuppressed: Dissecting the conundrum of safety and efficacy

Hajjar Joud

Year : 2019| Volume: 2| Issue : 3 | Page no: 53-54

   This article has been cited by
 
1 In the era of immune checkpoint inhibitor therapy, can we safely expand to patients with immunodeficiency?
MehmetAsim Bilen,Razelle Kurzrock
Journal of Immunotherapy and Precision Oncology. 2019; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
2 Cancer immunotherapy in the immunosuppressed patients and its relevance to clinical practice
Vaia Florou,Ignacio Garrido-Laguna
Journal of Immunotherapy and Precision Oncology. 2019; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]

 

Read this article